Silverfin false false 31/07/2025 01/08/2024 31/07/2025 K Patel 17/03/2015 R Patel 10/05/1996 15 May 2026 no description of principal activity 03196790 2025-07-31 03196790 bus:Director1 2025-07-31 03196790 bus:Director2 2025-07-31 03196790 2024-07-31 03196790 core:CurrentFinancialInstruments 2025-07-31 03196790 core:CurrentFinancialInstruments 2024-07-31 03196790 core:ShareCapital 2025-07-31 03196790 core:ShareCapital 2024-07-31 03196790 core:RetainedEarningsAccumulatedLosses 2025-07-31 03196790 core:RetainedEarningsAccumulatedLosses 2024-07-31 03196790 core:Goodwill 2024-07-31 03196790 core:Goodwill 2025-07-31 03196790 core:LandBuildings 2024-07-31 03196790 core:FurnitureFittings 2024-07-31 03196790 core:LandBuildings 2025-07-31 03196790 core:FurnitureFittings 2025-07-31 03196790 core:CostValuation 2024-07-31 03196790 core:CostValuation 2025-07-31 03196790 core:OtherMembersGroupNotDefinedElsewhere core:CurrentFinancialInstruments 2025-07-31 03196790 core:OtherMembersGroupNotDefinedElsewhere core:CurrentFinancialInstruments 2024-07-31 03196790 core:CurrentFinancialInstruments 1 2025-07-31 03196790 core:CurrentFinancialInstruments 1 2024-07-31 03196790 2024-08-01 2025-07-31 03196790 bus:FilletedAccounts 2024-08-01 2025-07-31 03196790 bus:SmallEntities 2024-08-01 2025-07-31 03196790 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 03196790 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 03196790 bus:Director1 2024-08-01 2025-07-31 03196790 bus:Director2 2024-08-01 2025-07-31 03196790 core:Goodwill core:TopRangeValue 2024-08-01 2025-07-31 03196790 core:LandBuildings core:TopRangeValue 2024-08-01 2025-07-31 03196790 core:FurnitureFittings 2024-08-01 2025-07-31 03196790 2023-08-01 2024-07-31 03196790 core:LandBuildings 2024-08-01 2025-07-31 iso4217:GBP xbrli:pure

Company No: 03196790 (England and Wales)

DEVKIPHARM LIMITED

Unaudited Financial Statements
For the financial year ended 31 July 2025
Pages for filing with the registrar

DEVKIPHARM LIMITED

Unaudited Financial Statements

For the financial year ended 31 July 2025

Contents

DEVKIPHARM LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 July 2025
DEVKIPHARM LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 July 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 5 1,446,951 1,277,642
Investments 6 1,267 1,267
1,448,218 1,278,909
Current assets
Stocks 89,159 85,713
Debtors 7 485,635 481,449
Cash at bank and in hand 270,634 495,926
845,428 1,063,088
Creditors: amounts falling due within one year 8 ( 648,156) ( 639,063)
Net current assets 197,272 424,025
Total assets less current liabilities 1,645,490 1,702,934
Provision for liabilities ( 52,614) ( 53,645)
Net assets 1,592,876 1,649,289
Capital and reserves
Called-up share capital 114,500 114,500
Profit and loss account 1,478,376 1,534,789
Total shareholders' funds 1,592,876 1,649,289

For the financial year ending 31 July 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Devkipharm Limited (registered number: 03196790) were approved and authorised for issue by the Board of Directors on 15 May 2026. They were signed on its behalf by:

R Patel
Director
DEVKIPHARM LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 July 2025
DEVKIPHARM LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 July 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Devkipharm Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2 Hales Drive, Canterbury, Kent, CT2 7AB, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

Current tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 5 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 50 years straight line
Fixtures and fittings 15 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.

2. Critical accounting judgements and key sources of estimation uncertainty

In the application of the Company’s accounting policies, the directors are required to make judgements that have a significant impact on the amounts recognised. The following are the critical judgements that the directors have made in the process of applying the Company’s accounting policies and that have the most significant effect on the amounts recognised in the financial statements.

3. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors: 18 22

4. Intangible assets

Goodwill Total
£ £
Cost
At 01 August 2024 11,955 11,955
At 31 July 2025 11,955 11,955
Accumulated amortisation
At 01 August 2024 11,955 11,955
At 31 July 2025 11,955 11,955
Net book value
At 31 July 2025 0 0
At 31 July 2024 0 0

5. Tangible assets

Land and buildings Fixtures and fittings Total
£ £ £
Cost
At 01 August 2024 1,409,167 593,142 2,002,309
Additions 201,828 29,024 230,852
At 31 July 2025 1,610,995 622,166 2,233,161
Accumulated depreciation
At 01 August 2024 350,052 374,615 724,667
Charge for the financial year 27,683 33,860 61,543
At 31 July 2025 377,735 408,475 786,210
Net book value
At 31 July 2025 1,233,260 213,691 1,446,951
At 31 July 2024 1,059,115 218,527 1,277,642

6. Fixed asset investments

Investments in subsidiaries

2025
£
Cost
At 01 August 2024 8
At 31 July 2025 8
Carrying value at 31 July 2025 8
Carrying value at 31 July 2024 8

Other investments Total
£ £
Cost or valuation before impairment
At 01 August 2024 1,259 1,259
At 31 July 2025 1,259 1,259
Carrying value at 31 July 2025 1,259 1,259
Carrying value at 31 July 2024 1,259 1,259

7. Debtors

2025 2024
£ £
Trade debtors 0 7,824
Amounts owed by connected persons 225,389 225,389
Other debtors 260,246 248,236
485,635 481,449

8. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 231,941 262,599
Amounts owed to Group undertakings 19,691 4,806
Amounts owed to connected companies 236,968 236,968
Taxation and social security 55,294 40,476
Other creditors 104,262 94,214
648,156 639,063

9. Related party transactions

Transactions with owners holding a participating interest in the entity

2025 2024
£ £
Amounts owed to a group company: 225,389 225,389
Amounts owed to a group company: 19,683 4,798
Amounts owed to a company related by common control: 236,968 236,968
Amounts owed to a group company: 8 8

Transactions with the entity's directors

2025 2024
£ £
Amounts owed to a director: 8,736 7,783